BioPharma Credit Ord (LSE:BPCR) - Investment trust price

Investment Trust Report

BioPharma Credit PLC BPCR

Last Price

Day Change

As of 27/03/2020
17:07:34 GMT | USD
Minimum 15 Minutes Delay.

Last Close0.88
Day Range0.88 - 0.90
52-Wk Range0.86 - 1.07
Mkt Cap Mil1,222.80
Yield %7.87
Estimated Nav1.00
Discount % %-11.00
12M Avg Disc %-0.02
Last Actual NAV1.00
Last NAV Date29/02/2020

Share Price Performance (USD)

Key Statistics (USD)
Total Assets1,373.932m
Net Assets1,373.932m
Market Capitalisation1,222.800m
Gross Gearing0%
Net Gearing0%
Average Daily Shares Traded (1 Yr)1.063m
Average Daily Value Traded (1 Yr)1.073m
Ongoing Charge (2019)1.12%
DomicileUnited Kingdom
Legal StructureClosed End Fund
Traded CurrencyUSD
Launch Date27 Mar 2017
Financial Year EndDec 2020
Next AGMJun 2020
NAV FrequencyMonthly
Dividend FrequencyQuarterly
Valuation Statistics
 27/03/20201 Yr High1 Yr Low
Category Discount---
Z-Statistics (1Yr)-3.30  

Total Returns (USD) 27/03/2020

 Chg (%)  
More ...
Cat Price-22.93
Cat NAV-4.48
Latest Dividends
TypeDividendEx-Dividend DateFinancial Year
Income - Special.012827/02/20202019

Morningstar Rating™

Not Rated

Morningstar® Category

USD Corporate Bond


Morningstar® Benchmark

Fund Structure
Share Type# of Shares
Ordinary Share1,373.932m

Investment Objective

The company will seek to generate long-term shareholder returns, predominantly in the form of sustainable income distributions from exposure to the life sciences industry. The company will seek to achieve its investment objective predominantly through direct or indirect exposure to Debt Assets. The Company may also invest in equity issued by a LifeSci Company, acquired directly from the LifeSci Company; or in the secondary market.
Pedro Gonzalez de Cosio27/03/2017
Pablo Legorreta27/03/2017
Martin Friedman27/03/2017


Colin Bond, Duncan Budge, Harry Hyman, Stephanie Leouzon, Jeremy Sillem
Fund prices are updated every weekday after the close of trading and before 11 p.m. wherever possible. All figures are as at Last Close, on a cum income basis with debt valued at fair and in traded currency unless otherwise stated (we do not fair value debt for split capital trusts). Performance returns are presented in U.S. Dollars (USD) and calculated on a capital only basis with debt valued at par.
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2020 Morningstar. All rights reserved.